Edward T.A. Fry, MD, president of the American College of Cardiology and a veteran cardiologist, shared his perspective on the many ways cardiologists can work to limit medical misinformation and disinformation. 

Cardiac amyloidosis can be especially challenging to identify and diagnose, making it a perfect target for advanced AI models.

The study, published in JACC: Cardiovascular Interventions, focused on data from more than 3,500 TAVR patients. 

Researchers have identified new details about the link between certain cancer therapies and heart complications. Could their work lead to key improvements in patient care?

New research published in Annals of Rheumatic Diseases and Hypertension examined the impact medications for different non-cardiovascular conditions can have on a patient's heart health.

According to data submitted to the FDA, the platform has been linked to an accuracy of 90%, sensitivity of 87.8% and specificity of 83%.

A wave of infections across the United States has led to a run on certain over-the-counter medications, and some retailers are limiting purchases to deal with the seasonal demand.

Health Exec caught up with Erik Swanson, senior vice president of data and analytics at Kaufman Hall, to learn more about the underlying trends throughout 2022 and what hospitals are bracing for in 2023.